期刊
SCIENCE
卷 332, 期 6035, 页码 1317-1322出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1199498
关键词
-
资金
- National Institutes of Health [CA103866, AI47389, ES015339, GM68762, CA112967]
- Department of Defense [W81XWH-07-0448]
- W.M. Keck Foundation
- LAM Foundation
- Dana-Farber Cancer Institute
- International Fulbright Science and Technology Award
- American Cancer Society
The mammalian target of rapamycin (mTOR) protein kinase is a master growth promoter that nucleates two complexes, mTORC1 and mTORC2. Despite the diverse processes controlled by mTOR, few substrates are known. We defined the mTOR-regulated phosphoproteome by quantitative mass spectrometry and characterized the primary sequence motif specificity of mTOR using positional scanning peptide libraries. We found that the phosphorylation response to insulin is largely mTOR dependent and that mTOR exhibits a unique preference for proline, hydrophobic, and aromatic residues at the +1 position. The adaptor protein Grb10 was identified as an mTORC1 substrate that mediates the inhibition of phosphoinositide 3-kinase typical of cells lacking tuberous sclerosis complex 2 (TSC2), a tumor suppressor and negative regulator of mTORC1. Our work clarifies how mTORC1 inhibits growth factor signaling and opens new areas of investigation in mTOR biology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据